Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Glatiramer acetate-induced hepatitis in a patient with multiple sclerosis.
Use of a biomarker in exposure-response analysis to support dose selection for fingolimod.
Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy.
Novel Targets in Multiple Sclerosis: to Oxidative Stress and Beyond.
Co-existence of tumefactive MS and hepatitis C: A need for further screening and new therapeutic challenge.
Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis.
Anticomplement therapy.
Defining a role for laquinimod in multiple sclerosis.
[Every fifth case of multiple sclerosis is familial.]
Down-regulation of Myelin Gene Expression in Human Oligodendrocytes by Nitric Oxide: Implications for Demyelination in Multiple Sclerosis.
Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod.
Explaining, not just predicting, drives interest in personal genomics.
Impaired early B cell tolerance in patients with rheumatoid arthritis.
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
[The effect of tobacco smoking on clinical effectiveness of immunomodulatory treatment in multiple sclerosis patients].
Magnetic resonance spectroscopy findings as related to fatigue and cognitive performance in multiple sclerosis patients with mild disability.
Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
Magnetic resonance imaging of blood brain/nerve barrier dysfunction and leukocyte infiltration: closely related or discordant?
Investigation of Fatigability during Repetitive Robot-Mediated Arm Training in People with Multiple Sclerosis.
Multiple sclerosis: Teriflunomide shows efficacy as an add-on therapy to IFN-β in patients with multiple sclerosis.
Quality of life in Polish patients with multiple sclerosis.
Does Infection-Induced Immune Activation Contribute to Dementia?
Kif13b Regulates PNS and CNS Myelination through the Dlg1 Scaffold.
Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis.

Pages